Clinical Trial Update: A Long-term Safety Study of QVM149 in Japanese Patients With Asthma [Phase 3]

View source ↗

Summary

Long-term safety study of QVM149 in Japanese patients with asthma has completed Phase 3; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QVM149 (Indacaterol acetate / glycopyrronium bromide / mometasone furoate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-04-07